https://alzheimereurope.newsweaver.com/Newsletter/ en-us 04 Jan 2022 11:31:20 CET 04 Jan 2022 11:31:20 CET https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true https://alzheimereurope.newsweaver.com/Newsletter/131tkempdpu?lang=en?rss=true Alzheimer Europe’s December 2021 newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/xtbvb6kgq4p/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/xtbvb6kgq4p/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues. [ https://alzheimereurope.newsweaver.com/Newsletter/xtbvb6kgq4p/external ] 04 Oct 2021 12:00:00 CEST 85a221a147cb80ceac96eb284a4960a5 Feature Article <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/2b/92a8976269fb1f449eddd2.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />Alzheimer Europe’s<strong> <a href="https://alzheimereurope.newsweaver.com/Newsletter/xtbvb6kgq4p/external" target="_blank" rel="noopener"><strong>December 2021 newsletter</strong></a></strong> brings you the latest news on developments in the dementia field, across Europe and beyond.</p> <p style="text-align: justify;"> </p> <p style="text-align: justify;">Summaries of a few of our top stories appear below.</p> <p style="text-align: justify;"> </p> <p style="text-align: justify;">Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues.</p> <p style="text-align: justify;"> </p> <p class="centered-only" style="text-align: center;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/xtbvb6kgq4p/external" target="_blank" rel="noopener"><img align="middle" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/28/6534b6316dfaa17784b267.jpg" width="150" height="75" hspace="0" vspace="0" alt="" /></a></p> https://alzheimereurope.newsweaver.com/Newsletter/17388i27xg3?lang=en?rss=true The European Group of Governmental Experts on Dementia held its final meeting of 2021, exchanging information and knowledge about the latest developments in dementia policy and practice. 19 countries were represented, as well as the European Commission and the WHO. 04 Jan 2022 12:00:00 CET 50b1fdf36c24034676b2d01ded4ecabb Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/61/991a377d7ca3f16628554b.jpg" style="margin: 5px;" width="150" height="86" hspace="5" vspace="5" alt="" />The European Group of Governmental Experts on Dementia held its final meeting of 2021, exchanging information and knowledge about the latest developments in dementia policy and practice. 19 countries were represented, as well as the European Commission and the WHO.</p> https://www.alzheimer-europe.org/news/european-group-governmental-experts-meets-online-0 https://alzheimereurope.newsweaver.com/Newsletter/1f84ejtbzxy?lang=en?rss=true On 17 December 2021, the European Medicines Agency (EMA), in a decision closely watched by the European dementia community, decided not to authorise aducanumab for the treatment of mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s dementia. 04 Jan 2022 12:00:00 CET a8e2e1651e98e2469bd78c5cfd5f267a Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/7d/1c16dc44ca0ece36462908.png" style="margin: 5px;" width="150" height="150" hspace="5" vspace="5" alt="" />On 17 December 2021, the European Medicines Agency (EMA), in a decision closely watched by the European dementia community, decided not to authorise aducanumab for the treatment of mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s dementia.</p> https://www.alzheimer-europe.org/news/european-medicines-agency-rejects-marketing-authorisation-application-aducanumab https://alzheimereurope.newsweaver.com/Newsletter/68hunk4yykw?lang=en?rss=true We are pleased to announce that videos of the 31st Alzheimer Europe Conference sessions (plenary, parallel and symposia) are now available on demand. If you were not previously registered for the event, but would like to gain access to these videos, you can still register for a reduced fee. 04 Jan 2022 12:00:00 CET 3d96699eba64119f878a3b47a4540a4c Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/96/0ce4ff039c9bb42e224b04.jpg" style="margin: 5px;" width="150" height="93" hspace="5" vspace="5" alt="" />We are pleased to announce that videos of the 31st Alzheimer Europe Conference sessions (plenary, parallel and symposia) are now available on demand. If you were not previously registered for the event, but would like to gain access to these videos, you can still register for a reduced fee.</p> https://www.alzheimer-europe.org/news/videos-31st-alzheimer-europe-conference-31aec-are-now-available-demand https://alzheimereurope.newsweaver.com/Newsletter/rb6ozvmc123?lang=en?rss=true The EU-FINGERS consortium is proud to announce the official launch of its website. EU-FINGERS is, by means of a precision medicine approach, working on the topic of the prevention of Alzheimer’s disease and builds on the work of similar existing European studies. 04 Jan 2022 12:00:00 CET 905c3d544ee361647dffa557e768c8a0 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v3files/shard1/56305/fe/b2db56c3df92f9ef58f864.png" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />The EU-FINGERS consortium is proud to announce the official launch of its website. EU-FINGERS is, by means of a precision medicine approach, working on the topic of the prevention of Alzheimer’s disease and builds on the work of similar existing European studies.</p> https://www.alzheimer-europe.org/news/eu-fingers-project-launches-its-website